Articles From: Cheniere Partners Announces Upsizing and Pricing of Senior Secured Notes due 2024 by Sabine Pass Liquefaction to China Commercial Credit Prices Secondary Public Offering


2014/5/13
HOUSTON , May 13, 2014 /PRNewswire/ -- Cheniere Energy Partners, L.P. ("Cheniere Partners") (NYSE MKT: CQP) announced today that its wholly owned subsidiary, Sabine Pass Liquefaction, LLC ("Sabine Pass Liquefaction"), has upsized and priced its previously announced offering of Senior Secured Notes due 2024 ("SPL 2024 Notes"). The principal amount of the offering has been increased from the initially announced $1.5 billion to $2.0 billion .
Sign-up for Cheniere Partners Announces Upsizing and Pricing of Senior Secured Notes due 2024 by Sabine Pass Liquefaction investment picks
CHEVIOT, Ohio, May 21, 2014 (GLOBE NEWSWIRE) -- Cheviot Financial Corp.
Sign-up for Cheviot Financial Corp. Announces Dividend investment picks
The Board of Directors of Chevron Corporation (NYSE: CVX) today declared a quarterly dividend of one dollar and seven cents ($1.07) per share, payable June 10, 2014, to holders of common stock as shown on the transfer records of the Corporation at the close of business on May 19, 2014.
Sign-up for Chevron Announces Quarterly Dividend investment picks
NEW YORK (MarketWatch) -- Chevron Corp (CVX) said it earned $4.5 billion, or $2.36 a share, in the first quarter, down from $6.2 billion, or $3.18 a share, in the same period a year ago, weighed down by lower prices and volumes for crude oil.
Sign-up for Chevron earnings crimped by lower prices, volumes for crude oil investment picks
2014/5/2
By Michael Calia Chevron Corp.
Sign-up for Chevron earnings hit by lower production investment picks
SAN RAMON, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Chevron Corporation (NYSE:CVX) , one of the world's leading energy companies, will hold its quarterly earnings conference call on Friday, May 2, 2014, at 11:00 a.m. ET (8:00 a.m. PT). Conference Call Information: Date: Friday, May 2, 2014 Time: 11:00 a.m. ET / 8:00 a.m. PT Dial-in # (Listen-only mode): 703-639-1116 / 866-219-5256 Conference ID #: 1635880 To access the live webcast, visit www.chevron.com .
Sign-up for Chevron First Quarter 2014 Earnings Conference Call investment picks
2014/5/1
By Gillian Tan The Portillo Restaurant Group Inc., which describes itself as the largest privately owned restaurant company in the Midwest, has hired Piper Jaffray to explore its financial alternatives, including a sale of its fast-casual division.
Sign-up for Chicago fast-casual chain Portillo's on block investment picks
2014/5/9
NAPERVILLE, Ill.
Sign-up for Chicago Rivet & Machine Co. Announces First Quarter Results of Operations investment picks
2014/5/13
NAPERVILLE, Ill.
Sign-up for Chicago Rivet & Machine Co. Declares Dividend investment picks
CHICOPEE, Mass., April 25, 2014 (GLOBE NEWSWIRE) -- Chicopee Bancorp, Inc. (the "Company") (Nasdaq:CBNK) , the holding company for Chicopee Savings Bank (the "Bank"), announced the unaudited results of operations for the three months ended March 31, 2014.
Sign-up for Chicopee Bancorp, Inc. Reports First Quarter Results and Announces Quarterly Cash Dividend of $0.07 Per Share investment picks
2014/5/4
Alliance of Australian and U.S. researchers and children's cancer advocates focused on developing drugs as potential treatments for neuroblastoma, the most common solid form of childhood cancer SYDNEY and COLUMBUS, Ohio , May 4, 2014 /PRNewswire/ -- Researchers and children's cancer advocates in Australia and the U.S. have formed a unique research and development alliance to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of solid cancer affecting infants.
Sign-up for Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers investment picks
DURHAM, N.C., April 9, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment of M.
Sign-up for Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer investment picks
DURHAM, N.C., May 19, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it is offering to sell 6,200,000 shares of its common stock in an underwritten public offering.
Sign-up for Chimerix Announces Commencement of Public Offering of Common Stock investment picks
DURHAM, N.C., May 9, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial results for the first quarter 2014.
Sign-up for Chimerix Announces First Quarter 2014 Financial Results investment picks
DURHAM, N.C., April 1, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment of Lisa Ricciardi to the Company's Board of Directors.
Sign-up for Chimerix Appoints Lisa Ricciardi to Board of Directors investment picks
DURHAM, N.C., May 20, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the pricing of an underwritten public offering of 7,300,000 shares of its common stock at a price to the public of $14.22 per share.
Sign-up for Chimerix Prices Public Offering of Common Stock investment picks
DURHAM, N.C., May 16, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it has regained the worldwide rights to CMX157, Chimerix's novel lipid acyclic nucleoside phosphonate, from Merck, known as MSD outside the United States and Canada.
Sign-up for Chimerix Regains Worldwide Rights to CMX157 investment picks
DURHAM, N.C., May 2, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it will report financial results for the first quarter ending March 31, 2014, on Friday, May 9, 2014, before the market opens.
Sign-up for Chimerix to Announce First Quarter Financial Results on May 9, 2014 investment picks
DURHAM, N.C., May 6, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced three presentations on its investigational broad-spectrum antiviral brincidofovir (BCV, CMX001) at the 27 th International Conference on Antiviral Research (ICAR) being held May 12-16, 2014 at the Raleigh Convention Center in Raleigh, NC.
Sign-up for Chimerix's Brincidofovir (CMX001) Data Accepted for Three Presentations at 27th International Conference on Antiviral Research investment picks
http://media.marketwire.com/attachments/201405/75357_chinaauto.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1116042&ProfileId=051205&sourceType=1 TIANJIN, CHINA --
Sign-up for China Auto Logistics Reports 2014 First Quarter Results investment picks
WUHAN, China , May 19, 2014 /PRNewswire-FirstCall/ -- China Automotive Systems, Inc. ("CAAS" or the "Company") (NASDAQ: CAAS) , a leading power steering components and systems supplier in China , announced today that it has entered into an agreement to acquire a 51.0% equity control position in Fujian Qiaolong Special Purpose Vehicle Co., Ltd.
Sign-up for China Automotive Systems Announces First Acquisition investment picks
WUHAN, China , May 14, 2014 /PRNewswire-FirstCall/ -- China Automotive Systems, Inc. ("CAAS" or the "Company") (NASDAQ: CAAS) , a leading power steering components and systems supplier in China , today announced its unaudited financial results for the first quarter ended March 31, 2014 .
Sign-up for China Automotive Systems Reports 2014 First-Quarter Results investment picks
-Teleconference to be held at 8:00 A.M. EDT/8:00 P.M. Beijing Time- WUHAN, China , May 1, 2014 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) , a leading power steering components and systems supplier in China, today announced that it will issue financial results for the 2014 first quarter ended March 31, 2014 on Wednesday, May 14, 2014 before the market opens.
Sign-up for China Automotive Systems To Announce 2014 First Quarter Financial Results on May 14, 2014 investment picks
2014/4/29
BEIJING , April 29, 2014 /PRNewwire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release first quarter 2014 financial results on Tuesday, May 6, 2014 after the market closes.
Sign-up for China Biologic Products to Report First Quarter 2014 Financial Results investment picks
2014/5/6
1Q14 Total Sales Increase 4.1% to $56.3Million 1Q14 Operating Margin Increases to 49.7% from 48.1% 1Q14 Non-GAAP Net Income Increases 16.3% to $ 19.1Million BEIJING , May 6, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its unaudited financial results for the first quarter of 2014.
Sign-up for China Biologic Reports Financial Results for the First Quarter of 2014 investment picks
2014/5/2
JINJIANG, China , May 2, 2014 /PRNewswire/ -- China Ceramics Co., Ltd.
Sign-up for China Ceramics Announces Delays In Filing its Fiscal 2013 Annual Report, Suspension of Trading, Changes In Its Board of Directors, And Preliminary Unaudited 2013 Financial Results investment picks
2014/5/2
JINJIANG, China , May 2, 2014 /PRNewswire/ -- China Ceramics Co., Ltd.
Sign-up for China Ceramics Announces Receipt of Nasdaq Non-Compliance Letter & Opportunity To Submit A Plan of Compliance investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1113688&ProfileId=051205&sourceType=1 SUZHOU, CHINA --
Sign-up for China Commercial Credit Prices Secondary Public Offering investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cheniere Partners Announces Upsizing and Pricing of Senior Secured Notes due 2024 by Sabine Pass Liquefaction to China Commercial Credit Prices Secondary Public Offering
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry